Researchers of a new study say that two patients with leukemia continued to be in remission a decade after they were first infused with the experimental CAR T-cell therapy that turned their immune cells into cancer-killing cells. In 2010, Doug Olson and Bill Ludwig, participated in an experimental phase 1 clinical trial of the immunotherapy, after their cancer had mutated and no longer responded to the standard treatments. Both were battling chronic lymphocytic leukemia (CLL), a type of blood and bone marrow cancer. Olsen was diagnosed in 1996 and Lugwig in 2000. Dr. Carl H. June, a senior author, and director of the Center for Cellular Immunotherapies at the University of Pennsylvania says Olsen is basically cured. “We can say it was a cure for Doug, because these are the most mature and oldest results available reported in scientific literature. … Ten years on, no leukemia cells, and we still …
RSS Feed | The Epoch Times